STOCK TITAN

MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

MIMEDX Group (Nasdaq: MDXG) has announced its upcoming first quarter 2025 financial results release and conference call schedule. The company will disclose its operating and financial results for Q1 2025 (ended March 31) after market close on Wednesday, April 30, 2025.

The senior management team will host a webcast and conference call at 4:30 p.m. Eastern Time on the same day. Investors can access the call through dedicated U.S. (877-407-6184) and International (201-389-0877) lines using Conference ID 13752696. A replay of the webcast will be available on www.mimedx.com for approximately 30 days following the event.

MIMEDX Group (Nasdaq: MDXG) ha annunciato la pubblicazione dei risultati finanziari del primo trimestre 2025 e il programma della conference call. L'azienda comunicherà i risultati operativi e finanziari del Q1 2025 (terminato il 31 marzo) dopo la chiusura del mercato, mercoledì 30 aprile 2025.

Il team di alta dirigenza terrà una webcast e una conference call alle 16:30 ora della costa est nello stesso giorno. Gli investitori potranno partecipare alla chiamata tramite le linee dedicate USA (877-407-6184) e internazionali (201-389-0877) utilizzando il codice conference ID 13752696. La registrazione della webcast sarà disponibile su www.mimedx.com per circa 30 giorni dopo l'evento.

MIMEDX Group (Nasdaq: MDXG) ha anunciado la publicación de sus resultados financieros del primer trimestre de 2025 y el calendario de la conferencia telefónica. La compañía divulgará sus resultados operativos y financieros del Q1 2025 (finalizado el 31 de marzo) después del cierre del mercado, el miércoles 30 de abril de 2025.

El equipo directivo llevará a cabo una retransmisión en vivo y una conferencia telefónica a las 4:30 p.m. hora del Este el mismo día. Los inversores podrán acceder a la llamada a través de las líneas dedicadas en EE. UU. (877-407-6184) e internacionales (201-389-0877) usando el ID de conferencia 13752696. La grabación de la retransmisión estará disponible en www.mimedx.com durante aproximadamente 30 días después del evento.

MIMEDX Group (나스닥: MDXG)는 2025년 1분기 재무 실적 발표 및 컨퍼런스 콜 일정을 공지했습니다. 회사는 2025년 1분기(3월 31일 종료) 운영 및 재무 실적을 2025년 4월 30일 수요일 장 마감 후에 공개할 예정입니다.

경영진은 같은 날 동부 표준시 오후 4시 30분에 웹캐스트와 컨퍼런스 콜을 진행합니다. 투자자들은 미국 전용 번호(877-407-6184)와 국제 번호(201-389-0877)를 통해 컨퍼런스 ID 13752696로 통화에 참여할 수 있습니다. 웹캐스트 녹화는 이벤트 후 약 30일간 www.mimedx.com에서 시청 가능합니다.

MIMEDX Group (Nasdaq : MDXG) a annoncé la publication de ses résultats financiers du premier trimestre 2025 ainsi que le calendrier de sa conférence téléphonique. La société communiquera ses résultats opérationnels et financiers pour le T1 2025 (clôturé le 31 mars) après la fermeture des marchés, le mercredi 30 avril 2025.

L'équipe de direction tiendra une webdiffusion et une conférence téléphonique à 16h30, heure de l'Est le même jour. Les investisseurs pourront accéder à l'appel via les lignes dédiées aux États-Unis (877-407-6184) et internationales (201-389-0877) en utilisant le code conférence 13752696. La rediffusion de la webdiffusion sera disponible sur www.mimedx.com pendant environ 30 jours après l'événement.

MIMEDX Group (Nasdaq: MDXG) hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 sowie den Zeitplan für die Telefonkonferenz angekündigt. Das Unternehmen wird die operativen und finanziellen Ergebnisse für Q1 2025 (Ende 31. März) nach Börsenschluss am Mittwoch, 30. April 2025 bekanntgeben.

Das Führungsteam wird am selben Tag um 16:30 Uhr Eastern Time eine Webcast-Übertragung und Telefonkonferenz abhalten. Investoren können über die speziellen US-amerikanischen (877-407-6184) und internationalen (201-389-0877) Leitungen mit der Konferenz-ID 13752696 teilnehmen. Eine Aufzeichnung des Webcasts wird für etwa 30 Tage nach der Veranstaltung auf www.mimedx.com verfügbar sein.

Positive
  • None.
Negative
  • None.

MARIETTA, Ga., April 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2025 after the market close on Wednesday, April 30, 2025. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13752696

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com


FAQ

When will MIMEDX (MDXG) release its Q1 2025 earnings?

MIMEDX will release Q1 2025 earnings after market close on Wednesday, April 30, 2025.

What time is MIMEDX's Q1 2025 earnings conference call?

The earnings conference call is scheduled for 4:30 p.m. Eastern Time on April 30, 2025.

How can investors access MIMEDX's Q1 2025 earnings call?

Investors can access via U.S. line (877-407-6184), International line (201-389-0877), or webcast using Conference ID 13752696.

How long will MIMEDX's Q1 2025 earnings call replay be available?

The webcast replay will be available for approximately 30 days on www.mimedx.com after the event.
Mimedx Group Inc

NASDAQ:MDXG

MDXG Rankings

MDXG Latest News

MDXG Stock Data

1.01B
144.34M
2.72%
69.9%
2.78%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
MARIETTA